Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2020

01-05-2020 | Care | Original Research

Translating CKD Research into Primary Care Practice: a Group-Randomized Study

Authors: Cara B. Litvin, MD, MS, Paul J. Nietert, PhD, Ruth G. Jenkins, PhD, Andrea M. Wessell, PharmD, Lynne S. Nemeth, PhD, RN, Steven M. Ornstein, MD

Published in: Journal of General Internal Medicine | Issue 5/2020

Login to get access

Abstract

Background

Chronic kidney disease (CKD) is common in the primary care setting. Early interventions may prevent progression of renal disease and reduce risk for cardiovascular complications, yet quality gaps have been documented. Successful approaches to improve identification and management of CKD in primary care are needed.

Objective

To assess whether implementation of a primary care improvement model results in improved identification and management of CKD

Design

18-month group-randomized study

Participants

21 primary care practices in 13 US states caring for 107,094 patients

Interventions

To promote implementation of CKD improvement strategies, intervention practices received clinical quality measure (CQM) reports at least quarterly, hosted an on-site visit and 2 webinars, and sent clinician/staff representatives to a “best practice” meeting. Control practices received CQM reports at least quarterly.

Main Measures

Changes in practice adherence to a set of 11 CKD CQMs

Key Results

We observed significantly greater improvements among intervention practices for annual screening for albuminuria in patients with diabetes or hypertension (absolute change 22% in the intervention group vs. − 2.6% in the control group, p < 0.0001) and annual monitoring for albuminuria in patients with CKD (absolute change 21% in the intervention group vs. − 2.0% in the control group, p < 0.0001). Avoidance of NSAIDs in patients with CKD declined in both intervention and control groups, with a significantly greater decline in the control practices (absolute change − 5.0% in the intervention group vs. − 10% in the control group, p < 0.0001). There were no other significant changes found for the other CQMs. Variable implementation of CKD improvement strategies was noted across the intervention practices.

Conclusions

Implementation of a primary care improvement model designed to improve CKD identification and management resulted in significantly improved care on 3 out of 11 CQMs. Incomplete adoption of improvement strategies may have limited further improvement. Improving CKD identification and management likely requires a longer and more intensive intervention.
Literature
1.
go back to reference Saran R, Li Y, Robinson B. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis.66(1 (suppl 2)):S1-S306. Saran R, Li Y, Robinson B. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis.66(1 (suppl 2)):S1-S306.
2.
go back to reference Wouters OJ, O’Donoghue DJ, Ritchie J, Kanavos PG, Narva AS. Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol 2015;11(8):491–502.PubMedPubMedCentral Wouters OJ, O’Donoghue DJ, Ritchie J, Kanavos PG, Narva AS. Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol 2015;11(8):491–502.PubMedPubMedCentral
3.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305.CrossRef Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305.CrossRef
4.
go back to reference Foster MC, Rawlings AM, Marrett E, et al. Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. Am Heart J 2013;166(1):150–156.PubMedPubMedCentral Foster MC, Rawlings AM, Marrett E, et al. Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. Am Heart J 2013;166(1):150–156.PubMedPubMedCentral
5.
go back to reference Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians’ knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med 2006;19(1):54–61.PubMed Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians’ knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med 2006;19(1):54–61.PubMed
6.
go back to reference Philipneri MD, Rocca Rey LA, Schnitzler MA, et al. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 2008;12(1):41–52.PubMed Philipneri MD, Rocca Rey LA, Schnitzler MA, et al. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 2008;12(1):41–52.PubMed
7.
go back to reference Shahinian VB, Saran R. The role of primary care in the management of the chronic kidney disease population. Adv Chronic Kidney Dis 2010;17(3):246–253.PubMed Shahinian VB, Saran R. The role of primary care in the management of the chronic kidney disease population. Adv Chronic Kidney Dis 2010;17(3):246–253.PubMed
8.
go back to reference Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–352.PubMed Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–352.PubMed
9.
go back to reference de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol 2006;17(8):2120–2126.PubMed de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol 2006;17(8):2120–2126.PubMed
10.
go back to reference Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004;17(10):986–993.PubMed Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004;17(10):986–993.PubMed
11.
go back to reference Palmer SC, Navaneethan SD, Craig JC, et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 2014;5:CD007784. Palmer SC, Navaneethan SD, Craig JC, et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 2014;5:CD007784.
12.
go back to reference Blood Pressure Lowering Treatment Trialists C, Ninomiya T, Perkovic V, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. Bmj. 2013;347:f5680. Blood Pressure Lowering Treatment Trialists C, Ninomiya T, Perkovic V, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. Bmj. 2013;347:f5680.
13.
go back to reference Holtkamp FA, de Zeeuw D, de Graeff PA, et al. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Eur Heart J 2011;32(12):1493–1499.PubMed Holtkamp FA, de Zeeuw D, de Graeff PA, et al. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Eur Heart J 2011;32(12):1493–1499.PubMed
14.
go back to reference Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135(2):73–87.PubMed Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135(2):73–87.PubMed
15.
go back to reference Sarnak MJ, Greene T, Wang X, et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med. 2005;142(5):342–351.PubMed Sarnak MJ, Greene T, Wang X, et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med. 2005;142(5):342–351.PubMed
16.
go back to reference Shurraw S, Hemmelgarn B, Lin M, et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171(21):1920–1927.PubMed Shurraw S, Hemmelgarn B, Lin M, et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171(21):1920–1927.PubMed
17.
go back to reference Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–853. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–853.
18.
go back to reference Gooch K, Culleton BF, Manns BJ, et al. NSAID use and progression of chronic kidney disease. Am J Med. 2007;120(3):280 e281–287. Gooch K, Culleton BF, Manns BJ, et al. NSAID use and progression of chronic kidney disease. Am J Med. 2007;120(3):280 e281–287.
19.
go back to reference KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013(3):19–62. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013(3):19–62.
20.
go back to reference KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2(5):337–414. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2(5):337–414.
21.
go back to reference Tuot DS, Powe NR. Chronic kidney disease in primary care: an opportunity for generalists. J Gen Intern Med 2011;26(4):356–358.PubMedPubMedCentral Tuot DS, Powe NR. Chronic kidney disease in primary care: an opportunity for generalists. J Gen Intern Med 2011;26(4):356–358.PubMedPubMedCentral
22.
go back to reference Litvin CB, Nietert PJ, Wessell AM, Jenkins RG, Ornstein SM. Recognition and management of CKD in primary care. Am J Kidney Dis 2011;57(4):646–647.PubMedPubMedCentral Litvin CB, Nietert PJ, Wessell AM, Jenkins RG, Ornstein SM. Recognition and management of CKD in primary care. Am J Kidney Dis 2011;57(4):646–647.PubMedPubMedCentral
23.
go back to reference Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD. Primary care management of chronic kidney disease. J Gen Intern Med 2011;26(4):386–392.PubMed Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD. Primary care management of chronic kidney disease. J Gen Intern Med 2011;26(4):386–392.PubMed
24.
go back to reference Israni RK, Shea JA, Joffe MM, Feldman HI. Physician characteristics and knowledge of CKD management. Am J Kidney Dis 2009;54(2):238–247.PubMed Israni RK, Shea JA, Joffe MM, Feldman HI. Physician characteristics and knowledge of CKD management. Am J Kidney Dis 2009;54(2):238–247.PubMed
25.
go back to reference Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T. CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis 2006;47(1):72–77.PubMed Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T. CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis 2006;47(1):72–77.PubMed
26.
go back to reference Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis 2010;17(3):225–236.PubMedPubMedCentral Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis 2010;17(3):225–236.PubMedPubMedCentral
27.
go back to reference Tuot DS, Plantinga LC, Hsu CY, Powe NR. Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? Am J Nephrol 2012;35(2):191–197.PubMedPubMedCentral Tuot DS, Plantinga LC, Hsu CY, Powe NR. Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? Am J Nephrol 2012;35(2):191–197.PubMedPubMedCentral
28.
go back to reference Greer RC, Cooper LA, Crews DC, Powe NR, Boulware LE. Quality of patient-physician discussions about CKD in primary care: a cross-sectional study. Am J Kidney Dis 2011;57(4):583–591.PubMed Greer RC, Cooper LA, Crews DC, Powe NR, Boulware LE. Quality of patient-physician discussions about CKD in primary care: a cross-sectional study. Am J Kidney Dis 2011;57(4):583–591.PubMed
29.
go back to reference Rettig RA, Norris K, Nissenson AR. Chronic kidney disease in the United States: a public policy imperative. Clin J Am Soc Nephrol 2008;3(6):1902–1910.PubMed Rettig RA, Norris K, Nissenson AR. Chronic kidney disease in the United States: a public policy imperative. Clin J Am Soc Nephrol 2008;3(6):1902–1910.PubMed
30.
go back to reference Diamantidis CJ, Powe NR, Jaar BG, Greer RC, Troll MU, Boulware LE. Primary care-specialist collaboration in the care of patients with chronic kidney disease. Clin J Am Soc Nephrol 2011;6(2):334–343.PubMedPubMedCentral Diamantidis CJ, Powe NR, Jaar BG, Greer RC, Troll MU, Boulware LE. Primary care-specialist collaboration in the care of patients with chronic kidney disease. Clin J Am Soc Nephrol 2011;6(2):334–343.PubMedPubMedCentral
31.
go back to reference Haley WE, Beckrich AL, Sayre J, et al. Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit. Am J Kidney Dis 2015;65(1):67–79.PubMed Haley WE, Beckrich AL, Sayre J, et al. Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit. Am J Kidney Dis 2015;65(1):67–79.PubMed
32.
go back to reference Fink HA, Ishani A, Taylor BC, et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2012;156(8):570–581.PubMed Fink HA, Ishani A, Taylor BC, et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2012;156(8):570–581.PubMed
33.
go back to reference Berns JS, Ellison DH, Linas SL, Rosner MH. Training the next generation’s nephrology workforce. Clin J Am Soc Nephrol. Sep 5 2014;9(9):1639–1644. Berns JS, Ellison DH, Linas SL, Rosner MH. Training the next generation’s nephrology workforce. Clin J Am Soc Nephrol. Sep 5 2014;9(9):1639–1644.
34.
go back to reference Brosius FC, 3rd, Hostetter TH, Kelepouris E, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation. Hypertension. 2006;48(4):751–755.PubMed Brosius FC, 3rd, Hostetter TH, Kelepouris E, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation. Hypertension. 2006;48(4):751–755.PubMed
35.
go back to reference American Diabetes A. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019;42(Suppl 1):S124-S138. American Diabetes A. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019;42(Suppl 1):S124-S138.
36.
go back to reference Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–1252.PubMed Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–1252.PubMed
38.
go back to reference Litvin CB, Ornstein SM. Quality indicators for primary care: an example for chronic kidney disease. J Ambulatory Care Manag 2014;37(2):171–178. Litvin CB, Ornstein SM. Quality indicators for primary care: an example for chronic kidney disease. J Ambulatory Care Manag 2014;37(2):171–178.
39.
go back to reference Nietert PJ, Jenkins RG, Nemeth LS, Ornstein SM. An application of a modified constrained randomization process to a practice-based cluster randomized trial to improve colorectal cancer screening. Contemp Clin Trials 2009;30(2):129–132.PubMed Nietert PJ, Jenkins RG, Nemeth LS, Ornstein SM. An application of a modified constrained randomization process to a practice-based cluster randomized trial to improve colorectal cancer screening. Contemp Clin Trials 2009;30(2):129–132.PubMed
40.
go back to reference Weissman NW, Allison JJ, Kiefe CI, et al. Achievable benchmarks of care: the ABCs of benchmarking. J Eval Clin Pract 1999;5(3):269–281.PubMed Weissman NW, Allison JJ, Kiefe CI, et al. Achievable benchmarks of care: the ABCs of benchmarking. J Eval Clin Pract 1999;5(3):269–281.PubMed
41.
go back to reference Nemeth LS. Synthesizing Lessons Learned Within a Practice-Based Research Network (PPRNet). 26th Annual Conference of the Southern Nursing Research Society; Feb 25, 2012, 2012; New Orleans, LA. Nemeth LS. Synthesizing Lessons Learned Within a Practice-Based Research Network (PPRNet). 26th Annual Conference of the Southern Nursing Research Society; Feb 25, 2012, 2012; New Orleans, LA.
42.
go back to reference Nemeth LS. Making Sense of Electronic Medical Record Adoption as Complex Interventions in Primary Health Care: Synthesizing Lessons Learned With Complex Interventions in a Research Network (PPRNet). Innovations for Health System Improvement: Balancing Costs, Quality and Equity; Annual CAHSPR Conference 2012; 2012; Montreal, Quebec, Canada. Nemeth LS. Making Sense of Electronic Medical Record Adoption as Complex Interventions in Primary Health Care: Synthesizing Lessons Learned With Complex Interventions in a Research Network (PPRNet). Innovations for Health System Improvement: Balancing Costs, Quality and Equity; Annual CAHSPR Conference 2012; 2012; Montreal, Quebec, Canada.
43.
go back to reference Nemeth LS, Nietert PJ, Ornstein SM. High performance in screening for colorectal cancer: a Practice Partner Research Network (PPRNet) case study. J Am Board Fam Med 2009;22(2):141–146.PubMedPubMedCentral Nemeth LS, Nietert PJ, Ornstein SM. High performance in screening for colorectal cancer: a Practice Partner Research Network (PPRNet) case study. J Am Board Fam Med 2009;22(2):141–146.PubMedPubMedCentral
44.
go back to reference Nemeth LS, Wessell AM, Jenkins RG, Nietert PJ, Liszka HA, Ornstein SM. Strategies to accelerate translation of research into primary care within practices using electronic medical records. J Nurs Care Qual 2007;22(4):343–349.PubMed Nemeth LS, Wessell AM, Jenkins RG, Nietert PJ, Liszka HA, Ornstein SM. Strategies to accelerate translation of research into primary care within practices using electronic medical records. J Nurs Care Qual 2007;22(4):343–349.PubMed
45.
go back to reference Nemeth LS, Ornstein SM, Jenkins RG, Wessell AM, Nietert PJ. Implementing and evaluating electronic standing orders in primary care practice: a PPRNet study. J Am Board Fam Med 2012;25(5):594–604.PubMed Nemeth LS, Ornstein SM, Jenkins RG, Wessell AM, Nietert PJ. Implementing and evaluating electronic standing orders in primary care practice: a PPRNet study. J Am Board Fam Med 2012;25(5):594–604.PubMed
46.
go back to reference Greer RC, Powe NR, Jaar BG, Troll MU, Boulware LE. Effect of primary care physicians’ use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions. BMC Nephrol 2011;12:1.PubMedPubMedCentral Greer RC, Powe NR, Jaar BG, Troll MU, Boulware LE. Effect of primary care physicians’ use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions. BMC Nephrol 2011;12:1.PubMedPubMedCentral
47.
go back to reference Tsang JY, Blakeman T, Hegarty J, Humphreys J, Harvey G. Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review. Implement Sci. 2016;11:47.PubMedPubMedCentral Tsang JY, Blakeman T, Hegarty J, Humphreys J, Harvey G. Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review. Implement Sci. 2016;11:47.PubMedPubMedCentral
48.
go back to reference Litvin CB, Hyer JM, Ornstein SM. Use of Clinical Decision Support to Improve Primary Care Identification and Management of Chronic Kidney Disease (CKD). J Am Board Fam Med 2016;29(5):604–612.PubMed Litvin CB, Hyer JM, Ornstein SM. Use of Clinical Decision Support to Improve Primary Care Identification and Management of Chronic Kidney Disease (CKD). J Am Board Fam Med 2016;29(5):604–612.PubMed
49.
go back to reference Carroll JK, Pulver G, Dickinson LM, et al. Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care: A Cluster Randomized Trial. JAMA Netw Open. 2018;1(6):e183377.PubMedPubMedCentral Carroll JK, Pulver G, Dickinson LM, et al. Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care: A Cluster Randomized Trial. JAMA Netw Open. 2018;1(6):e183377.PubMedPubMedCentral
50.
go back to reference Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis 2014;63(5):789–797.PubMed Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis 2014;63(5):789–797.PubMed
51.
go back to reference Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis 2010;55(3):452–462.PubMed Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis 2010;55(3):452–462.PubMed
Metadata
Title
Translating CKD Research into Primary Care Practice: a Group-Randomized Study
Authors
Cara B. Litvin, MD, MS
Paul J. Nietert, PhD
Ruth G. Jenkins, PhD
Andrea M. Wessell, PharmD
Lynne S. Nemeth, PhD, RN
Steven M. Ornstein, MD
Publication date
01-05-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 5/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05353-4

Other articles of this Issue 5/2020

Journal of General Internal Medicine 5/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.